{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Apatinib", "Apoptosis", "Breast cancer", "Doxorubicin", "Toxicology"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37921980", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1007/s11033-023-08860-0"], "Journal": {"ISSN": "1573-4978", "JournalIssue": {"Volume": "50", "Issue": "12", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Molecular biology reports", "ISOAbbreviation": "Mol Biol Rep"}, "ArticleTitle": "Apatinib increases anticancer potential of doxorubicin in breast cancer cells.", "Pagination": {"StartPage": "10137", "EndPage": "10145", "MedlinePgn": "10137-10145"}, "Abstract": {"AbstractText": ["In recent years, drug resistance has become a most important challenge in chemotherapy of malignancies. Here, we investigated a novel approach to enhance therapeutic potential of doxorubicin (Dox as a common chemotherapeutic drug) by co-administration of apatinib (Apa as a monoclonal antibody) in breast cancer treatment.", "Effects of Apa, Dox, and their combinations (Apa-Dox) were investigated on proliferation of MDA-MB-231 breast cancer cells by MTT assay. Moreover, migration and invasion of the treated and untreated control cancer cells were evaluated by scratch and transwell methods, respectively. Apoptosis percentage of the treated cancer cells was investigated by flow cytometry method. Finally, apoptosis-, metastasis-, and angiogenesis-related gene expression at mRNA and protein levels in the cancer cells were investigated by Real-Time PCR and western blotting methods, respectively. Our results indicated that treatments of cancer cells by Apa, Dox, and Apa-Dox significantly decrease proliferation, migration, and invasion of MDA-MB-231 breast cancer cells. Treatments of the breast cancer cells by Apa, Dox, and Apa-Dox significantly increase apoptosis percentage. We observed that anticancer effects of Apa, Dox, and Apa-Dox may due to modification of apoptosis-, metastasis-, and angiogenesis-related gene expression (at mRNA and protein level) in the breast cancer cells. However, anticancer potential of Apa-Dox combination was significantly more than Apa and Dox monotherapy.", "We demonstrated that Apa significantly increases anticancer potential of Dox in MDA-MB-231 breast cells. However, further in-vitro, in-vivo, and clinical studies are required to confirm this result."], "CopyrightInformation": "\u00a9 2023. The Author(s), under exclusive licence to Springer Nature B.V."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran."}], "LastName": "Aghaei", "ForeName": "Elnaz", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran. hossien4040@gmail.com."}, {"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, Iran. hossien4040@gmail.com."}], "LastName": "Soltanzadeh", "ForeName": "Hossein", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran."}], "LastName": "Kohan", "ForeName": "Leila", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Baqiyatallah Research Center for Gastroenterology and Liver Disease (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran."}], "LastName": "Heiat", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Biol Rep", "NlmUniqueID": "0403234", "ISSNLinking": "0301-4851"}, "ChemicalList": [{"RegistryNumber": "5S371K6132", "NameOfSubstance": "apatinib"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["metabolism"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["genetics"], "DescriptorName": "RNA, Messenger"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Li S, Wang Y, Feng C, Wu G, Ye Y, Tian J (2017) Calycosin inhibits the migration and invasion of human breast cancer cells by down-regulation of Foxp3 expression. Cell Physiol Biochem 44:1775\u20131844", "ArticleIdList": ["10.1159/000485784", "29241196"]}, {"Citation": "Mehralizadeh H, Nazari A, Oruji F, Roostaie M, Hosseininozari G, Yazdani O, Esbati R, Roudini K (2023) Cytokine sustained delivery for cancer therapy; special focus on stem cell-and biomaterial-based delivery methods. Pathol-Res Pract 247:154528", "ArticleIdList": ["10.1016/j.prp.2023.154528", "37257247"]}, {"Citation": "Firouzi Amoodizaj F, Baghaeifar S, Taheri E, Farhoudi Sefidan Jadid M, Safi M, Seyyed Sani N, Hajazimian S, Isazadeh A, Shanehbandi D (2020) Enhanced anticancer potency of doxorubicin in combination with Curcumin in gastric adenocarcinoma. J Biochem Mol Toxicol 34:22486", "ArticleIdList": ["10.1002/jbt.22486"]}, {"Citation": "Isazadeh A, Hajazimian S, Shadman B, Safaei S, Bedoustani AB, Chavoshi R, Shanehbandi D, Mashayekhi M, Nahaei M, Baradaran B (2020) Anti-cancer Effects of Probiotic Lactobacillus acidophilus for Colorectal Cancer Cell Line Caco-2 through apoptosis induction. Pharm Sci 27:262\u2013267", "ArticleIdList": ["10.34172/PS.2020.52"]}, {"Citation": "Farhoudi Jadid M, Aghaei E, Taheri E, Seyyedsani N, Chavoshi R, Abbasi S, Khorrami A, Goleij P, Hajazimian S, Taefehshokr S, Isazadeh A (2021) Melatonin increases the anticancer potential of doxorubicin in Caco-2 colorectal cancer cells. Environ Toxicol 36:1061\u20131069", "ArticleIdList": ["10.1002/tox.23105"]}, {"Citation": "Maroufi NF, Vahedian V, Hemati S, Rashidi MR, Akbarzadeh M, Zahedi M, Pouremamali F, Isazadeh A, Taefehshokr S, Hajazimian S, Seraji N (2020) Targeting cancer stem cells by melatonin: effective therapy for cancer treatment. Pathol Res Pract 216:152919", "ArticleIdList": ["10.1016/j.prp.2020.152919", "32171553"]}, {"Citation": "Yu W-C, Zhang K-Z, Chen S-G, Liu W-F (2018) Efficacy and safety of apatinib in patients with intermediate/advanced hepatocellular carcinoma: a prospective observation study. Medicine 97:e9704", "ArticleIdList": ["10.1097/MD.0000000000009704", "29505026", "5779795"]}, {"Citation": "Maroufi NF, Vahedian V, Akbarzadeh M, Mohammadian M, Zahedi M, Isazadeh A, Pouremamali F, Taefehshokr S, Heidari M, Rashidi M, Nouri M (2020) The apatinib inhibits breast cancer cell line MDA-MB-231 in vitro by inducing apoptosis, cell cycle arrest, and regulating nuclear factor-\u03baB (NF-\u03baB) and mitogen-activated protein kinase (MAPK) signaling pathways. Breast Cancer 27(4):613\u2013620", "ArticleIdList": ["10.1007/s12282-020-01055-6", "32026267"]}, {"Citation": "Sadeghi-Aliabadi H, Minaiyan M, Dabestan A (2010) Cytotoxic evaluation of doxorubicin in combination with simvastatin against human cancer cells. Res Pharm Sci 5:127", "ArticleIdList": ["22049271", "3203264"]}, {"Citation": "Shabani S, Moghadam MF, Gargari SL (2021) Isolation and characterization of a novel GRP78-specific single-chain variable fragment (scFv) using ribosome display method. Med Oncol 38(9):115", "ArticleIdList": ["10.1007/s12032-021-01561-3", "34390413"]}, {"Citation": "Hajazimian S, Maleki M, Mehrabad SD, Isazadeh A (2020) Human Wharton\u2019s jelly stem cells inhibit endometriosis through apoptosis induction. Reproduction 159:549\u2013558", "ArticleIdList": ["10.1530/REP-19-0597", "32155128"]}, {"Citation": "Soltanzadeh H, Acik L, Turk M, Houshmand M, Shahsavari G (2018) Antimicrobial, antioxidant, cytotoxic and apoptotic activities of Satureja khuzestanica. Gazi Med J 29(3):264\u2013270"}, {"Citation": "Kaboli PJ, Shabani S, Sharma S, Nasr MP, Yamaguchi H, Hung MC (2022) Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates. Am J Cancer Res 12:1671"}, {"Citation": "Taheri E, Ghorbani S, Safi M, Sani NS, Amoodizaj FF, Heidari M, Chavoshi R, Hajazimian S, Isazadeh A, Heidari M (2020) Inhibition of colorectal cancer cell line CaCo-2 by essential oil of eucalyptus camaldulensis through induction of apoptosis. Acta Med Iran 58:260\u2013265"}, {"Citation": "Kozani PS, Shabani S (2021) Adverse events and Side Effects of chimeric Antigen receptor (CAR) T cell therapy in patients with hematologic malignancies. Trends Med Sci 1:e116301"}, {"Citation": "Isazadeh H, Oruji F, Shabani S, Behroozi J, Nasiri H, Isazadeh A, Akbari M (2023) Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities. Mol Biol Rep. :1\u20135"}, {"Citation": "Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami AR, Karimi G (2011) Effect of curcumin on doxorubicin-induced cytotoxicity in H9c2 cardiomyoblast cells. Iran J Basic Med Sci 14:49\u201356"}, {"Citation": "Abbasi S, Bazyar R, Saremi MA, Alishiri G, Seyyedsani N, Jadid MF, Khorrami A, Golmarz PE, Jahangirzadeh G, Bedoustan AB, Hajazimian S (2021) Wharton jelly stem cells inhibits AGS gastric cancer cells through induction of apoptosis and modification of MAPK and NF-\u03baB signaling pathways. Tissue Cell 73:101597", "ArticleIdList": ["10.1016/j.tice.2021.101597", "34358919"]}, {"Citation": "Oruji F, Baghbani Arani F, Mahdavi Ortakand M (2018) Evaluation of the gene expression of IL-1\u03b2 and Casp-1 related to inflammation process in glomerulonephritis patients. J Anim Environ 10:477\u2013482"}, {"Citation": "Hashemi A, Bigdeli R, Shahnazari M, Oruji F, Fattahi S, Panahnejad E, Ghadri A, Movahedi-Asl E, Mahdavi-Ourtakand M, Asgary V, Baghbani-Arani F (2021) Evaluation of inflammasome activation in peripheral blood mononuclear cells of hemodialysis treated patients with glomerulonephritis. Iran J Pharm Res 20:609", "ArticleIdList": ["34904012", "8653650"]}, {"Citation": "Ghaleh AS, Saghati S, Rahbarghazi R, Hassani A, Kaleybar LS, Geranmayeh MH, Hassanpour M, Rezaie J, Soltanzadeh H (2021) Static and dynamic culture of human endothelial cells encapsulated inside alginate-gelatin microspheres. Microvasc Res 137:104174", "ArticleIdList": ["10.1016/j.mvr.2021.104174"]}, {"Citation": "Hseu YC, Lin RW, Shen YC, Lin KY, Liao JW, Thiyagarajan V, Yang HL (2020) Flavokawain B and doxorubicin work synergistically to impede the propagation of gastric cancer cells via ROS-mediated apoptosis and autophagy pathways. Cancers 12:2475", "ArticleIdList": ["10.3390/cancers12092475", "32882870", "7564097"]}, {"Citation": "Jadid MF, Shademan B, Chavoshi R, Seyyedsani N, Aghaei E, Taheri E, Goleij P, Hajazimian S, Karamad V, Behroozi J, Sabet MN (2021) Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano\u2010encapsulation on PANC\u20101 pancreatic cancer cell line. Environ Toxicol 36:1043\u20131051", "ArticleIdList": ["10.1002/tox.23103", "33496383"]}, {"Citation": "Fath MK, Naderi M, Hamzavi H, Ganji M, Shabani S, Khalesi B, Pourzardosht N, Hashemi ZS, Khalili S (2022) Molecular Mechanisms and therapeutic effects of different vitamins and minerals in COVID-19 patients. J Trace Elem Med Biol 73:127044", "ArticleIdList": ["10.1016/j.jtemb.2022.127044", "35901669", "9297660"]}, {"Citation": "Ahmadi E, Zarghami N, Jafarabadi MA, Alizadeh L, Khojastehfard M, Yamchi MR, Salehi R (2019) Enhanced anticancer potency by combination chemotherapy of HT-29 cells with biodegradable, pH-sensitive nanoparticles for co-delivery of hydroxytyrosol and doxorubicin. J Drug Deliv Sci Technol 51:721\u2013735", "ArticleIdList": ["10.1016/j.jddst.2019.03.003"]}, {"Citation": "Salzillo A, Ragone A, Spina A, Naviglio S, Sapio L (2021) Chlorogenic acid enhances doxorubicin-mediated cytotoxic effect in Osteosarcoma cells. Int J Mol Sci 22:8586", "ArticleIdList": ["10.3390/ijms22168586", "34445291", "8395331"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "8", "Day": "2"}, {"Year": "2023", "Month": "9", "Day": "27"}, {"Year": "2023", "Month": "11", "Day": "27", "Hour": "12", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "18", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "12", "Minute": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37921980", "10.1007/s11033-023-08860-0", "10.1007/s11033-023-08860-0"]}}], "PubmedBookArticle": []}